Greater Cannabis Valuation
| GCAN Stock | USD 0.0004 0.0001 20.00% |
Greater Cannabis seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Greater Cannabis from evaluating the firm fundamentals such as Price To Earning of 3.90 X, current valuation of 688.64 K, and Return On Asset of -0.39 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Greater Cannabis' price fluctuation is out of control at this time. Calculation of the real value of Greater Cannabis is based on 3 months time horizon. Increasing Greater Cannabis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Greater Cannabis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Greater Pink Sheet. However, Greater Cannabis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.0E-4 | Real 3.84E-4 | Hype 4.59E-4 | Naive 3.75E-4 |
The intrinsic value of Greater Cannabis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Greater Cannabis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Greater Cannabis helps investors to forecast how Greater pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Greater Cannabis more accurately as focusing exclusively on Greater Cannabis' fundamentals will not take into account other important factors: Greater Cannabis Total Value Analysis
Greater Cannabis is currently forecasted to have valuation of 688.64 K with market capitalization of 534.91 K, debt of 702.44 K, and cash on hands of 311.2 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Greater Cannabis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
688.64 K | 534.91 K | 702.44 K | 311.2 K |
Greater Cannabis Investor Information
About 68.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.0. Greater Cannabis had not issued any dividends in recent years. Based on the key indicators related to Greater Cannabis' liquidity, profitability, solvency, and operating efficiency, Greater Cannabis is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Greater Cannabis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Greater Cannabis has an asset utilization ratio of 3.21 percent. This suggests that the Company is making $0.0321 for each dollar of assets. An increasing asset utilization means that Greater Cannabis is more efficient with each dollar of assets it utilizes for everyday operations.Greater Cannabis Ownership Allocation
Greater Cannabis has a total of 668.64 Million outstanding shares. Greater Cannabis retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.13 (percent) of Greater Cannabis outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Greater Cannabis Profitability Analysis
The company reported the previous year's revenue of 12.63 K. Net Loss for the year was (602.23 K) with loss before overhead, payroll, taxes, and interest of (5.03 K).About Greater Cannabis Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Greater Cannabis. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Greater Cannabis based exclusively on its fundamental and basic technical indicators. By analyzing Greater Cannabis's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Greater Cannabis's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Greater Cannabis. We calculate exposure to Greater Cannabis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Greater Cannabis's related companies.The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. The company was founded in 2014 and is based in Baltimore, Maryland. Greater Cannabis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Greater Cannabis' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Greater Cannabis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Greater Cannabis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Greater Cannabis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Greater Cannabis' revenue streams: Identify Greater Cannabis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Greater Cannabis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Greater Cannabis' growth potential: Evaluate Greater Cannabis' management, business model, and growth potential.
- Determine Greater Cannabis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Greater Cannabis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Greater Cannabis Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 489.5 M | |
| Retained Earnings | -3.9 M |
Other Information on Investing in Greater Pink Sheet
Greater Cannabis financial ratios help investors to determine whether Greater Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Greater with respect to the benefits of owning Greater Cannabis security.